This study states that Although studies with definitive evidence have not been reported yet, pivotal research projects are ongoing to start answering these not-well clarified issues. Several risk scoring systems have been developed to predict the postoperative short-term6 and long-term7 life expectancy of patients with ACS. These are rapid tools that could help clinicians in discriminating those patients who will benefit from CEA, starting from available clinical and routine blood test variables. Despite these advantages, external validation of the scoring systems is urgently needed to provide real utility. Another support for patient enrollment could derive from geometric features and personalized computational fluid dynamics. Starting from patient-specific data imaging, it is possible to detect areas exposed to turbulent flow. If applied on a wide scale, these results could improve the outcomes of CEA, in particular in terms of the restenosis rates.8 The limitations of engineering analysis remain the high computational costs and the current difficult applicability outside of academic studies. Collaboration between vascular surgeons and engineers will allow for the creation of simple, usable, and shareable forecast models.
Reference link- https://www.jvascsurg.org/article/S0741-5214(20)32683-5/fulltext
